<html>
<head>
  <title>Schedule IV [Code of Federal Regulations]</title>
  <basefont face="Tahoma" size="2" />
  <meta http-equiv="Content-Type" content="text/html;charset=utf-8" />
  <meta name="exporter-version" content="Evernote Windows/307027 (en-US, DDL); Windows/10.0.0 (Win64);"/>
  <style>
    body, td {
      font-family: Tahoma;
      font-size: 10pt;
    }
  </style>
</head>
<body>
<a name="5597"/>
<h1>Schedule IV [Code of Federal Regulations]</h1>
<div>
<table bgcolor="#D4DDE5" border="0">
<tr><td><b>Created:</b></td><td><i>1/5/2018 7:15 PM</i></td></tr>
<tr><td><b>Updated:</b></td><td><i>1/5/2018 7:15 PM</i></td></tr>
<tr><td><b>Author:</b></td><td><i>David Patrone</i></td></tr>
<tr><td><b>Source:</b></td><td><a href="https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=1308.14"><i>https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=1308.14</i></a></td></tr>
</table>
</div>
<br/>

<div>
<span><div><table><colgroup><col></col></colgroup><tbody><tr valign="top"><td><table cellpadding="0" cellspacing="0"><colgroup><col></col></colgroup><tbody><tr><td><div>[Code of Federal Regulations]</div></td></tr><tr><td><div>[Title 21, Volume 9]</div></td></tr><tr><td><div>[Revised as of April 1, 2017]</div></td></tr><tr><td><div>[CITE: 21CFR1308.14]</div></td></tr></tbody></table></td></tr></tbody></table><div><br/></div><div><br/></div><div><br/></div><table><colgroup><col></col></colgroup><tbody><tr valign="top"><td><table align="center" cellpadding="0" cellspacing="0"><colgroup><col></col></colgroup><tbody><tr valign="top"><td align="center"><div>TITLE 21--FOOD AND DRUGS</div></td></tr></tbody></table></td></tr><tr valign="top"><td><table align="center" cellpadding="0" cellspacing="0"><colgroup><col></col></colgroup><tbody><tr><td align="center"><div>CHAPTER II--DRUG ENFORCEMENT ADMINISTRATION</div><div>DEPARTMENT OF JUSTICE</div></td></tr></tbody></table></td></tr><tr valign="top"><td><table align="center" cellpadding="0" cellspacing="0"><colgroup><col></col></colgroup><tbody><tr valign="bottom"><td align="center"><div><br/></div></td></tr></tbody></table></td></tr></tbody></table><div><a href="https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=1308">PART 1308 -- SCHEDULES OF CONTROLLED SUBSTANCES</a></div><div><span>Schedules</span></div><table><colgroup><col></col></colgroup><tbody><tr valign="top"><td><div>Sec. 1308.14 Schedule IV.</div></td></tr></tbody></table><table><colgroup><col></col></colgroup><tbody><tr valign="top"><td><div><span>(a) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.</span></div><div><span>(b)</span><span> </span><span>Narcotic drugs.</span><span> </span><span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:</span></div><table border="1"><colgroup><col></col><col></col></colgroup><tbody><tr><td align="left"><div>(1) Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit</div></td><td align="right"><div>9167</div></td></tr><tr><td align="left"><div>(2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane)</div></td><td align="right"><div>9278</div></td></tr><tr><td align="left"><div>(3) 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol)</div></td><td align="right"><div>9752</div></td></tr></tbody></table><div><span>(c)</span><span> </span><span>Depressants.</span><span> </span><span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:</span></div><table border="1"><colgroup><col></col><col></col></colgroup><tbody><tr><td align="left"><div>(1) Alfaxalone</div></td><td align="right"><div>2731</div></td></tr><tr><td align="left"><div>(2) Alprazolam</div></td><td align="right"><div>2882</div></td></tr><tr><td align="left"><div>(3) Barbital</div></td><td align="right"><div>2145</div></td></tr><tr><td align="left"><div>(4) Bromazepam</div></td><td align="right"><div>2748</div></td></tr><tr><td align="left"><div>(5) Camazepam</div></td><td align="right"><div>2749</div></td></tr><tr><td align="left"><div>(6) Carisoprodol</div></td><td align="right"><div>8192</div></td></tr><tr><td align="left"><div>(7) Chloral betaine</div></td><td align="right"><div>2460</div></td></tr><tr><td align="left"><div>(8) Chloral hydrate</div></td><td align="right"><div>2465</div></td></tr><tr><td align="left"><div>(9) Chlordiazepoxide</div></td><td align="right"><div>2744</div></td></tr><tr><td align="left"><div>(10) Clobazam</div></td><td align="right"><div>2751</div></td></tr><tr><td align="left"><div>(11) Clonazepam</div></td><td align="right"><div>2737</div></td></tr><tr><td align="left"><div>(12) Clorazepate</div></td><td align="right"><div>2768</div></td></tr><tr><td align="left"><div>(13) Clotiazepam</div></td><td align="right"><div>2752</div></td></tr><tr><td align="left"><div>(14) Cloxazolam</div></td><td align="right"><div>2753</div></td></tr><tr><td align="left"><div>(15) Delorazepam</div></td><td align="right"><div>2754</div></td></tr><tr><td align="left"><div>(16) Diazepam</div></td><td align="right"><div>2765</div></td></tr><tr><td align="left"><div>(17) Dichloralphenazone</div></td><td align="right"><div>2467</div></td></tr><tr><td align="left"><div>(18) Estazolam</div></td><td align="right"><div>2756</div></td></tr><tr><td align="left"><div>(19) Ethchlorvynol</div></td><td align="right"><div>2540</div></td></tr><tr><td align="left"><div>(20) Ethinamate</div></td><td align="right"><div>2545</div></td></tr><tr><td align="left"><div>(21) Ethyl loflazepate</div></td><td align="right"><div>2758</div></td></tr><tr><td align="left"><div>(22) Fludiazepam</div></td><td align="right"><div>2759</div></td></tr><tr><td align="left"><div>(23) Flunitrazepam</div></td><td align="right"><div>2763</div></td></tr><tr><td align="left"><div>(24) Flurazepam</div></td><td align="right"><div>2767</div></td></tr><tr><td align="left"><div>(25) Fospropofol</div></td><td align="right"><div>2138</div></td></tr><tr><td align="left"><div>(26) Halazepam</div></td><td align="right"><div>2762</div></td></tr><tr><td align="left"><div>(27) Haloxazolam</div></td><td align="right"><div>2771</div></td></tr><tr><td align="left"><div>(28) Ketazolam</div></td><td align="right"><div>2772</div></td></tr><tr><td align="left"><div>(29) Loprazolam</div></td><td align="right"><div>2773</div></td></tr><tr><td align="left"><div>(30) Lorazepam</div></td><td align="right"><div>2885</div></td></tr><tr><td align="left"><div>(31) Lormetazepam</div></td><td align="right"><div>2774</div></td></tr><tr><td align="left"><div>(32) Mebutamate</div></td><td align="right"><div>2800</div></td></tr><tr><td align="left"><div>(33) Medazepam</div></td><td align="right"><div>2836</div></td></tr><tr><td align="left"><div>(34) Meprobamate</div></td><td align="right"><div>2820</div></td></tr><tr><td align="left"><div>(35) Methohexital</div></td><td align="right"><div>2264</div></td></tr><tr><td align="left"><div>(36) Methylphenobarbital (mephobarbital)</div></td><td align="right"><div>2250</div></td></tr><tr><td align="left"><div>(37) Midazolam</div></td><td align="right"><div>2884</div></td></tr><tr><td align="left"><div>(38) Nimetazepam</div></td><td align="right"><div>2837</div></td></tr><tr><td align="left"><div>(39) Nitrazepam</div></td><td align="right"><div>2834</div></td></tr><tr><td align="left"><div>(40) Nordiazepam</div></td><td align="right"><div>2838</div></td></tr><tr><td align="left"><div>(41) Oxazepam</div></td><td align="right"><div>2835</div></td></tr><tr><td align="left"><div>(42) Oxazolam</div></td><td align="right"><div>2839</div></td></tr><tr><td align="left"><div>(43) Paraldehyde</div></td><td align="right"><div>2585</div></td></tr><tr><td align="left"><div>(44) Petrichloral</div></td><td align="right"><div>2591</div></td></tr><tr><td align="left"><div>(45) Phenobarbital</div></td><td align="right"><div>2285</div></td></tr><tr><td align="left"><div>(46) Pinazepam</div></td><td align="right"><div>2883</div></td></tr><tr><td align="left"><div>(47) Prazepam</div></td><td align="right"><div>2764</div></td></tr><tr><td align="left"><div>(48) Quazepam</div></td><td align="right"><div>2881</div></td></tr><tr><td align="left"><div>(49) Suvorexant</div></td><td align="right"><div>2223</div></td></tr><tr><td align="left"><div>(50) Temazepam</div></td><td align="right"><div>2925</div></td></tr><tr><td align="left"><div>(51) Tetrazepam</div></td><td align="right"><div>2886</div></td></tr><tr><td align="left"><div>(52) Triazolam</div></td><td align="right"><div>2887</div></td></tr><tr><td align="left"><div>(53) Zaleplon</div></td><td align="right"><div>2781</div></td></tr><tr><td align="left"><div>(54) Zolpidem</div></td><td align="right"><div>2783</div></td></tr><tr><td align="left"><div>(55) Zopiclone</div></td><td align="right"><div>2784</div></td></tr></tbody></table><div><span>(d)</span><span> </span><span>Fenfluramine.</span><span> </span><span>Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:</span></div><table border="1"><colgroup><col></col><col></col></colgroup><tbody><tr><td align="left"><div>(1) Fenfluramine</div></td><td align="right"><div>1670</div></td></tr></tbody></table><div><span>(e)</span><span> </span><span>Lorcaserin.</span><span> </span><span>Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:</span></div><table border="1"><colgroup><col></col><col></col></colgroup><tbody><tr><td align="left"><div>(1) Lorcaserin</div></td><td align="right"><div>1625</div></td></tr></tbody></table><div><span>(f)</span><span> </span><span>Stimulants.</span><span> </span><span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers:</span></div><table border="1"><colgroup><col></col><col></col></colgroup><tbody><tr><td align="left"><div>(1) Cathine ((+)-norpseudoephedrine)</div></td><td align="right"><div>1230</div></td></tr><tr><td align="left"><div>(2) Diethylpropion</div></td><td align="right"><div>1610</div></td></tr><tr><td align="left"><div>(3) Fencamfamin</div></td><td align="right"><div>1760</div></td></tr><tr><td align="left"><div>(4) Fenproporex</div></td><td align="right"><div>1575</div></td></tr><tr><td align="left"><div>(5) Mazindol</div></td><td align="right"><div>1605</div></td></tr><tr><td align="left"><div>(6) Mefenorex</div></td><td align="right"><div>1580</div></td></tr><tr><td align="left"><div>(7)Modafinil</div></td><td align="right"><div>1680</div></td></tr><tr><td align="left"><div>(8) Pemoline (including organometallic complexes and chelates thereof)</div></td><td align="right"><div>1530</div></td></tr><tr><td align="left"><div>(9) Phentermine</div></td><td align="right"><div>1640</div></td></tr><tr><td align="left"><div>(10) Pipradrol</div></td><td align="right"><div>1750</div></td></tr><tr><td align="left"><div>(11) Sibutramine</div></td><td align="right"><div>1675</div></td></tr><tr><td align="left"><div>(12) SPA ((-)-1-dimethylamino- 1,2-diphenylethane)</div></td><td align="right"><div>1635</div></td></tr></tbody></table><div><span>(g)</span><span> </span><span>Other substances.</span><span> </span><span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts:</span></div><table border="1"><colgroup><col></col><col></col></colgroup><tbody><tr><td align="left"><div>(1) Pentazocine</div></td><td align="right"><div>9709</div></td></tr><tr><td align="left"><div>(2) Butorphanol (including its optical isomers)</div></td><td align="right"><div>9720</div></td></tr><tr><td align="left"><div>(3) Eluxadoline (5-&lt;[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers (9725).</div></td><td align="right"><div><br/></div></td></tr></tbody></table><div><span>[39 FR 22143, June 20, 1974]</span></div><div><span>Editorial Note:</span></div><div><span>For Federal Register citations affecting 1308.14, see the List of CFR Sections Affected, which appears in the Finding Aids section of the printed volume and at</span><span> </span><span><a href="http://www.fdsys.gov/">www.fdsys.gov</a>.</span></div></td></tr></tbody></table><div><br/></div></div></span>
</div></body></html> 